Skip to main content

and
  1. No Access

    Chapter

    A Trial of ICRF-187 to Selectively Protect Against Chronic Adriamycin Cardiac Toxicity: Rationale and Preliminary Results of a Clinical Trial

    The wide spectrum of anthracycline activity as well as the unique cumulative dose related cardiac toxicity pose a significant clinical challenge. These drugs, particularly doxorubicin (AdriamycinR), constitute so...

    J. L. Speyer, M. D. Green, C. Ward in Organ Directed Toxicities of Anticancer Dr… (1988)